Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Progress Toward Precision Medicine in Frontline Treatment of Metastatic Renal Cell Carcinoma

Progress Toward Precision Medicine in Frontline Treatment of Metastatic Renal Cell Carcinoma This Viewpoint describes progress toward applying insight into immune checkpoint inhibitor and angiogenesis inhibitor drugs toward cases of metastatic renal cell carcinoma. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Oncology American Medical Association

Progress Toward Precision Medicine in Frontline Treatment of Metastatic Renal Cell Carcinoma

JAMA Oncology , Volume 6 (1) – Jan 5, 2020

Loading next page...
 
/lp/american-medical-association/progress-toward-precision-medicine-in-frontline-treatment-of-lZo0TPSrXn
Publisher
American Medical Association
Copyright
Copyright 2019 American Medical Association. All Rights Reserved.
ISSN
2374-2437
eISSN
2374-2445
DOI
10.1001/jamaoncol.2019.4716
Publisher site
See Article on Publisher Site

Abstract

This Viewpoint describes progress toward applying insight into immune checkpoint inhibitor and angiogenesis inhibitor drugs toward cases of metastatic renal cell carcinoma.

Journal

JAMA OncologyAmerican Medical Association

Published: Jan 5, 2020

References